Skip to main content

Statera Biopharma, Inc.

STABDelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001318641

Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.

Q1 2025 vs. Q4 2024

How the institutions holding Statera Biopharma, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of STAB: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders10−1
Shares1.00K0−1.00K (−100.0%)
Value$0$0$0

New holders (0)

Institutions that held Statera Biopharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

None.

Sold out (1)

Institutions that held Statera Biopharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of STAB in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Tucker Asset Management LLC1,000$0